We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where ...

OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services ...

In this article, we are going to take a look at where OncoCyte Corporation (NASDAQ:OCX) stands against other cheapest stocks that insiders are buying recently. Why should we be interested in ...

Oncocyte Corp (NASDAQ:OCX), currently trading at $2.37 with a market cap of $39.6 million, has seen a significant insider transaction as Chief Financial Officer James Andrea S. acquired shares of ...

IRVINE, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a pioneering diagnostics technology company, today announced that it has entered into securities purchase agreements ...

Oncocyte Corp (NASDAQ:OCX), a small-cap biotechnology company with a market capitalization of $39.6 million, has reported that Patrick W. Smith, a significant shareholder of the company ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...